Dupixent (dupilumab) - Sanofi, Regeneron
Eosinophilic Esophagitis Improvement Following Limited Dupilumab Therapy in a Woman with Cutaneous T-Cell Lymphoma (ACAAI 2026) - Oct 28, 2026 - Abstract #M735; Pres time: Nov 13, 2026; 04:15 PM - 06:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 11; No abstract available 
Clinical • Cutaneous T-cell Lymphoma • Eosinophilic Esophagitis • Gastrointestinal Disorder • Hematological Malignancies • Immunology • Lymphoma • T Cell Non-Hodgkin Lymphoma
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next